Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SGMO save search
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.4%
H: 2.37%
C: 0.66%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 1.96%
H: 9.62%
C: 0.0%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 5.49%
H: 2.84%
C: -0.65%
trials meeting set therapeutics therapy
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: -4.77%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 3.13%
H: 0.38%
C: -2.68%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: -2.15%
H: 2.58%
C: 0.92%
candidate payment for collaboration program therapeutics milestone
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-26 (Crawled : 20:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: -0.1%
H: 1.0%
C: -4.5%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 0.38%
H: 6.39%
C: 3.14%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.16%
H: 0.25%
C: -2.51%
nasdaq grants therapeutics
Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
Published: 2024-03-22 (Crawled : 13:00) - biospace.com/
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -5.18%
H: 0.54%
C: -23.59%
million direct offering therapeutics
Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
therapeutics
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13 (Crawled : 13:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
business year therapeutics financial results
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: -1.65%
H: 4.59%
C: 2.24%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 2.19%
H: 4.55%
C: -10.78%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.72%
H: 2.29%
C: 2.21%
ferguson medical therapeutics
Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 2.2%
H: 5.62%
C: 3.35%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 0.88%
H: 0.88%
C: -1.75%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.05%
H: 1.45%
C: 0.99%
candidate payment collaboration therapeutics therapy milestone
Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast
Published: 2024-02-21 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.0%
H: 0.92%
C: 0.92%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -6.78%
H: 13.64%
C: 12.27%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.14%
H: 0.58%
C: -1.65%
conference therapeutics
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research
Published: 2024-02-20 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 1.72%
H: 1.82%
C: -1.43%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -1.45%
H: 0.74%
C: -13.24%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.63%
H: 0.8%
C: -0.37%
disease alzheimer’s research preclinical tau program therapeutics therapy
Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 8.46%
H: 35.96%
C: 29.21%
st-920 fda disease approval prime ema therapeutics potential
Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference
Published: 2024-02-07 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 0.41%
H: 1.82%
C: 0.41%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 1.79%
H: 1.75%
C: -8.55%
conference life sciences therapeutics
Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 3.44%
H: 21.91%
C: 15.68%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -0.2%
H: 8.12%
C: -3.67%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.14%
H: 1.33%
C: 0.62%
conference therapeutics
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies
Published: 2024-01-02 (Crawled : 12:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.86%
H: 1.81%
C: 0.9%
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 24.76%
H: 11.3%
C: -14.53%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -0.17%
H: 9.33%
C: 2.56%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: -1.18%
H: 2.4%
C: 1.18%
license collaboration novartis therapeutics agreement
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program- IND filing expected in mid-2025 -
Published: 2023-12-06 (Crawled : 20:00) - biospace.com/
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 1.61%
H: 1.59%
C: 0.66%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 4.24%
H: 4.57%
C: -4.66%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.39%
H: 1.01%
C: 0.39%
candidate expected sclerosis therapeutics therapy
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
Published: 2023-12-06 (Crawled : 12:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 1.61%
H: 1.59%
C: 0.66%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 4.24%
H: 4.57%
C: -4.66%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.39%
H: 1.01%
C: 0.39%
candidate sclerosis program therapeutics therapy
Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results
Published: 2023-11-01 (Crawled : 22:00) - biospace.com/
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 3.14%
H: 1.54%
C: -9.11%
update therapeutics financial results
Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast
Published: 2023-10-30 (Crawled : 11:00) - globenewswire.com
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: 1.09%
H: 1.85%
C: 0.93%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 3.67%
H: 9.75%
C: 9.09%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.65%
H: 1.12%
C: 0.35%
conference therapeutics
Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and Webcast
Published: 2023-10-25 (Crawled : 22:00) - biospace.com/
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 2.39%
H: 4.59%
C: -3.46%
conference therapeutics
Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Published: 2023-10-24 (Crawled : 10:00) - biospace.com/
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 1.79%
H: 6.51%
C: -1.9%
pre-clinical congress cell research therapeutics therapy
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.